Inhibition of PFKP in renal tubular epithelial cell restrains TGF-β induced glycolysis and renal fibrosis
Shu Yang, Han Wu, Yanchun Li, Lixin Li, Jiaqing Xiang, Lin Kang, Guangyan Yang, Zhen Liang · 2023
Read Inhibition of PFKP in renal tubular epithelial cell restrains TGF-β induced glycolysis and renal fibrosis by Shu Yang, Han Wu, Yanchun Li, Lixin Li, Jiaqing Xiang, Lin Kang, Guangyan Yang, Zhen Liang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10716164.txt.
Description
Shu Yang and colleagues finger a sugar-burning enzyme as the switch that turns kidney scarring on, in this study from twenty twenty-three. Chronic kidney disease rewires tubule cells toward glycolysis, and the platelet form of phosphofructokinase, PFKP, is its rate limiter. In mice with a blocked ureter, forcing extra PFKP into tubules widened them, fed glycolysis, and spread fibrosis; silencing it did the opposite.
The upstream hand was the scarring signal TGF-beta, which docks a SMAD3-SP1 protein complex onto the PFKP gene to raise its output, confirmed in human tubule cells. A plant flavonoid, isorhamnetin, dialled the enzyme's elevation back and eased both glycolysis and fibrosis in the animals. The authors propose PFKP as a metabolic drug target for kidney fibrosis, a disease with few.
Catalog record
| CREATOR | Shu Yang, Han Wu, Yanchun Li, Lixin Li, Jiaqing Xiang, Lin Kang, Guangyan Yang, Zhen Liang |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |